Chen H and Pan J .2019 .Observation on the efficacy of hyperbaric oxygen combined with high flux hemodialysis in the treatment of 24 cases of diabetic nephropathy. Chin. J. Nautical Med, 26(3) : 256-259.
Ding XQ,Zhu JM .2018 .Research progress, problems and prospects in the diagnosis and treatment of diabetic nephropathy. , 41(2) : 73-77.
Dong HY,Yang YY,Han F,Xin HY,Ma JL HY .2019 .The effect of Bailing capsule combined with alprostadil on immune indexes and clinical efficacy in elderly patients with diabetic nephropathy. Pract, 33(3) : 285-287.
Ito D,Ikuma-Suwa E,Inoue K,Kaneko K,Yanagisawa M,Inukai K,Noda M,Shimada A .2017 .Effects of ipragliflozin on diabetic nephropathy and blood pressure in patients with type 2 diabetes: an open-label study. J. Clin. Med, 9(2) : 154-162.
Keating ST,Van Diepen JA,Riksen NP,El-Osta A .2018 .Epigenetics in diabetic nephropathy, immunity and metabolism. , 61(1) : 6-20.
Li HQ,An GF,Guo DS .2019 .The efficacy of prostadil-based multi-factor intervention for stage III diabetic nephropathy. J. Pract. Med, 35(12) : 1996-1999.
Li LL,Pu S,Fan QL,Wang X,Li SL .2019 .Analysis of circulating miRNA expression profiles in patients with diabetic nephropathy. J. China Med, 48(8) : 708-698.
Lin CX,Li GZ,Fang TY .2019 .Clinical effect of Danhong injection assisted with alprostadil in the treatment of elderly patients with diabetic nephropathy. Chin. Arch. Traditional Chin. Med, 37(6) : 1491-1493.
Lin JS,Yuan HQ,Yin ZL .2019 .The effect of hyperbaric oxygen on the morphological parameters of red blood cells and anemia-related indicators in patients with chronic kidney disease. Chron. Pathematology J., 20(1) : 85-87.
Liu W,Lai MZ,Guo SH .2018 .Resistin level in patients with type 2 diabetic nephropathy and its relationship with vascular endothelial function. J. Clinical Res., 35(8) : 1467-1470.
Nadolnik K,Skrypnik D,Skrypnik K,Bogdanski P .2018 .Diabetic nephropathy in the elderly-clinical practice. Rocz Panstw Zakl Hig., 69(4) : 327-334.
Oreno JA,Gomez-Guerrero C,Mas S C .2018 .Targeting inflammation in diabetic nephropathy: A tale of hope. Expert Opin. Investig. Drugs, 27(11) : 917-930.
Quan ZW,Kong TY,Ha L,Fan GJ .2018 .Effects of alprostadil on oxidative stress, inflammatory factors and vascular endothelial factors in elderly patients with diabetic nephropathy. Pract, 32(6) : 78-82.
Shen JJ,Wu Q,Huang D Q .2018 .Therapeutic effect of hyperbaric oxygen combined with Gubentongluo prescription on IgA nephropathy in mice. Chin. J. Nautical Med, 25(5) : 305-309.
Song QQ,Mo XQ,Huang C .2019 .The efficacy and mechanism of fenofibrate combined with alprostadil in the treatment of diabetic nephropathy. Guangdong Med, 40(9) : 1318-1321.
Tao HQ,Wang ZY,Yang LZ .2017 .Effects of hyperbaric oxygen therapy on serum neuron-specific enolase, transforming growth factor β1, vascular endothelial function and immune function in patients with hypertensive intracerebral hemorrhage. Int. J. Imm., 40(4) : 391-395.
Umanath K,Lewis JB K .2018 .. Update on diabetic nephropathy: core curriculum 2018. Am. J. Kidney Dis, 71(6) : 884-895.
Wang R,Wang R,An JL,Zhu YY,Tian YM,Yin FZ,Lu Q,Han GL,Zhang WD,Fu JJ .2017 .Effect of different doses of alprostadil assisted calcium dobesilate on renal function, inflammatory cytokines and oxidative stress levels in patients with diabetic nephropathy. Int. J. Geriatr., 38(5) : 211-214.
Wang XA,Chen HY,Ye SK .2018 .Efficacy of cilostazol combined with candesartan cilexetil dispersible tablets in the treatment of early diabetic nephropathy. Chin. J. Health Care Med, 20(6) : 52-55.
Xu TY,Xu TL,Cardio-Cerebral-Vascular Dis TL .2019 .Effect of hyperbaric oxygen therapy on neurological function recovery and cerebral edema in patients with hypertensive intracerebral hemorrhage. Prevent, 19(3) : 267-269.
Zeng SL,Li HL,Liang FL .2019 .Correlation analysis of microinflammatory state, nutritional status and immune function in patients with diabetic nephropathy. Progr, 19(20) : 3947-3950.
Zhang HL,Li NQ,Zhao B .2017 .The application value of hyperbaric oxygen in the treatment of primary nephrotic syndrome and its effect on patients' renal function. J. Harbin Med, 51(3) : 236-239.
Zhong HF,Zhou YH,Han XJ,Yang XH,Shen YM .2018 .-342 and Cystatin C for type 2 diabetic nephropathy. Labeled Imm. Clin. Med, 25(11) : 104-108.